tiprankstipranks
Pmv Pharmaceuticals, Inc. (PMVP)
NASDAQ:PMVP
US Market
PMVP
PMV Pharmaceuticals
RESEARCH TOOLSreports

PMV Pharmaceuticals (PMVP) Financial Statements

Compare
169 Followers

PMV Pharmaceuticals Financial Overview

PMV Pharmaceuticals's market cap is currently $69.86M. The company's EPS TTM is $-0.33; its P/E ratio is -0.84; PMV Pharmaceuticals is scheduled to report earnings on March 6, 2026, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -133.00K$ -1.14M$ -1.26M$ -650.00K$ -1.28M
Operating Income$ -86.21M$ -85.45M$ -80.13M$ -77.04M$ -58.29M
EBITDA$ -86.21M$ -73.67M$ -67.70M$ -72.68M$ -56.54M
Net Income$ -77.74M$ -58.71M$ -68.96M$ -73.32M$ -57.85M
Balance Sheet
Cash & Short-Term Investments$ 112.94M$ 169.45M$ 203.06M$ 241.05M$ 297.16M
Total Assets$ 116.56M$ 191.29M$ 252.15M$ 270.31M$ 331.57M
Total Debt$ 838.00K$ 1.19M$ 13.29M$ 13.98M$ 11.19M
Net Debt$ -37.15M$ -39.69M$ -24.42M$ -94.32M$ -161.27M
Total Liabilities$ 11.85M$ 15.21M$ 26.46M$ 24.28M$ 23.01M
Stockholders' Equity$ 104.71M$ 176.08M$ 225.69M$ 246.03M$ 308.56M
Cash Flow
Free Cash Flow$ -73.61M$ -51.94M$ -56.62M$ -71.74M$ -47.92M
Operating Cash Flow$ -73.58M$ -51.28M$ -55.66M$ -63.76M$ -46.57M
Investing Cash Flow$ 70.17M$ 53.35M$ -50.55M$ -1.37M$ -143.58M
Financing Cash Flow$ 505.00K$ 313.00K$ 35.58M$ 958.00K$ 2.02M
Currency in USD

PMV Pharmaceuticals Earnings and Revenue History

Income Statement >

PMV Pharmaceuticals Debt to Assets

Balance Sheet >

PMV Pharmaceuticals Cash Flow

Cash Flow >

PMV Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >